Novo Integrated Sciences Management
Management criteria checks 4/4
Novo Integrated Sciences' CEO is Rob Mattacchione, appointed in Oct 2018, has a tenure of 6.08 years. total yearly compensation is $185.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 6.77% of the company’s shares, worth $71.00K. The average tenure of the management team and the board of directors is 3 years and 3.7 years respectively.
Key information
Rob Mattacchione
Chief executive officer
US$185.0k
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 6.1yrs |
| CEO ownership | 6.8% |
| Management average tenure | 3yrs |
| Board average tenure | 3.7yrs |
Recent management updates
Recent updates
Slammed 49% Novo Integrated Sciences, Inc. (NASDAQ:NVOS) Screens Well Here But There Might Be A Catch
Jul 11
Novo Integrated Sciences, Inc. (NASDAQ:NVOS) Looks Just Right With A 26% Price Jump
Apr 18Novo Integrated Sciences prices 4M unit public offering at $.50/unit
Oct 14Novo Integrated Sciences expects to report over fivefold increase in Q3 revenue
Jul 11Health Check: How Prudently Does Novo Integrated Sciences (NASDAQ:NVOS) Use Debt?
Nov 23Does Novo Integrated Sciences (NASDAQ:NVOS) Have A Healthy Balance Sheet?
Aug 07Does Novo Integrated Sciences (NASDAQ:NVOS) Have A Healthy Balance Sheet?
Mar 02CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| May 31 2024 | n/a | n/a | -US$24m |
| Feb 29 2024 | n/a | n/a | -US$12m |
| Nov 30 2023 | n/a | n/a | -US$14m |
| Aug 31 2023 | US$185k | US$185k | -US$13m |
| May 31 2023 | n/a | n/a | -US$32m |
| Feb 28 2023 | n/a | n/a | -US$35m |
| Nov 30 2022 | n/a | n/a | -US$35m |
| Aug 31 2022 | US$185k | US$185k | -US$33m |
| May 31 2022 | n/a | n/a | -US$12m |
| Feb 28 2022 | n/a | n/a | -US$9m |
| Nov 30 2021 | n/a | n/a | -US$5m |
| Aug 31 2021 | US$47k | US$47k | -US$4m |
Compensation vs Market: Rob's total compensation ($USD185.00K) is below average for companies of similar size in the US market ($USD652.28K).
Compensation vs Earnings: Rob's compensation has been consistent with company performance over the past year.
CEO
Rob Mattacchione (56 yo)
6.1yrs
Tenure
US$185,000
Compensation
Mr. Robert Mattacchione, also known as Rob, is Chairman of the Board and Chief Executive Officer at Novo Integrated Sciences, Inc. since October 2018. He is the Co-Owner at Mattacchione Family Trust. He is...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & CEO | 6.1yrs | US$185.00k | 6.77% $ 71.0k | |
| COO & Director | 3.4yrs | US$434.56k | 0.043% $ 450.7 | |
| Principal Financial Officer & Principal Accounting Officer | 1.3yrs | no data | no data | |
| Chief Medical Officer & Chairman of Medical Advisory Board | 2.6yrs | no data | no data |
3.0yrs
Average Tenure
56yo
Average Age
Experienced Management: NVOS's management team is considered experienced (3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & CEO | 6.1yrs | US$185.00k | 6.77% $ 71.0k | |
| COO & Director | 10.3yrs | US$434.56k | 0.043% $ 450.7 | |
| Chief Medical Officer & Chairman of Medical Advisory Board | 3.6yrs | no data | no data | |
| Member of Medical Advisory Board | 3.6yrs | no data | no data | |
| Independent Director | 3.8yrs | US$15.00k | 0% $ 0 | |
| Independent Director | 3.8yrs | no data | 0% $ 0 | |
| Member of Medical Advisory Board | 3.6yrs | no data | no data | |
| Independent Director | 2.4yrs | no data | 0% $ 0 |
3.7yrs
Average Tenure
52.5yo
Average Age
Experienced Board: NVOS's board of directors are considered experienced (3.7 years average tenure).